1. Home
  2. PFAI vs ATNM Comparison

PFAI vs ATNM Comparison

Compare PFAI & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pinnacle Food Group Limited

PFAI

Pinnacle Food Group Limited

BUY

Current Price

$2.56

Market Cap

35.8M

ML Signal

BUY

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.03

Market Cap

31.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFAI
ATNM
Founded
2015
2000
Country
Canada
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.8M
31.7M
IPO Year
2024
2013

Fundamental Metrics

Financial Performance
Metric
PFAI
ATNM
Price
$2.56
$1.03
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.50
AVG Volume (30 Days)
5.1K
151.7K
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.17
EPS
N/A
0.71
Revenue
N/A
$90,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$1.46
Revenue Growth
N/A
11.11
52 Week Low
$1.78
$0.74
52 Week High
$4.93
$1.74

Technical Indicators

Market Signals
Indicator
PFAI
ATNM
Relative Strength Index (RSI) 50.54 57.45
Support Level $2.16 $0.98
Resistance Level $3.10 $1.13
Average True Range (ATR) 0.23 0.06
MACD 0.06 -0.00
Stochastic Oscillator 87.14 38.89

Price Performance

Historical Comparison
PFAI
ATNM

About PFAI Pinnacle Food Group Limited

Pinnacle Food Group Ltd is a provider of smart farming solutions focused on vertical and hydroponic farming. The company focuses on promoting sustainable food security by developing and building customized smart farming systems for customers based on the systematic integration of technology, hardware, and software, coupled with a full range of integrated supply and technical services. It sells hydroponic growing systems and technical support services to individual households and community groups, and is developing a hydroponic growing system for urban farms. Geographically, the company generates the majority revenue from Canada, followed by New Zealand.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.

Share on Social Networks: